DIN Registered Products: MI/MCI Mandatory Reporting

 In DIN, Regulatory Affairs

By: Teri Dickinson, Regulatory Affairs Group Manager

Methylisothiazolinone/methylchloroisothiazolinone (MI/MCI), a preservative sometimes know as Kathon, is no longer permitted in any leave-on cosmetic products in Canada. Companies selling DIN Registered products must report the levels of MI/MCI to Health Canada EVEN IF THERE IS NO MI/MCI IN YOUR PRODUCT.  Notification letters are due to Health Canada by April 18, 2016. Contact Dell Tech today if you require assistance submitting mandatory notifications to Health Canada by the due date.

DIN registered products include:

  • Pharmaceuticals
  • Sunscreen
  • Acne therapy products
  • Antiseptic skin cleansers
  • Anti-dandruff products
  • Athletes foot treatments,
  • Medicated skincare products
  • Diaper rash products
  • Throat lozenges
  • Disinfectants

Dell Tech Laboratories

Dell Tech has provided professional, confidential consulting services to the chemical specialty

industry in Canada, the USA, Europe, and Asia for the last 40 years.

Contact us today for more information.



Recommended Posts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

en_CAEnglish (Canada)